Clinical Trial Update: Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial combining liposomal irinotecan and capecitabine with enronsubemab plus short-course radiotherapy for locally advanced rectal/colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Enronsubemab
• Onivyde (irinotecan hydrochloride liposome injection)
• Xeloda (capecitabine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: RECRUITING